209 related articles for article (PubMed ID: 26504179)
41. Free light chains and heavy/light chains in monitoring POEMS patients.
Altinier S; Proko K; Zaninotto M; Ciubotaru D; Seguso M; Varagnolo M; Lessi F; Briani C; Adami F; Plebani M
Clin Chem Lab Med; 2016 Jun; 54(6):1065-71. PubMed ID: 27071150
[TBL] [Abstract][Full Text] [Related]
42. POEMS syndrome: the matter-of-fact approach.
Scarlato M; Previtali SC
Curr Opin Neurol; 2011 Oct; 24(5):491-6. PubMed ID: 21677582
[TBL] [Abstract][Full Text] [Related]
43. [POEMS syndrome and papilledema].
Schakal A; Cordonnier M; Soupart A
Bull Soc Belge Ophtalmol; 1992; 243():1-10. PubMed ID: 1302137
[TBL] [Abstract][Full Text] [Related]
44. Predicted and measured retinal nerve fiber layer thickness from time-domain optical coherence tomography compared with spectral-domain optical coherence tomography.
Schrems WA; Schrems-Hoesl LM; Bendschneider D; Mardin CY; Laemmer R; Kruse FE; Horn FK
JAMA Ophthalmol; 2015 Oct; 133(10):1135-43. PubMed ID: 26225533
[TBL] [Abstract][Full Text] [Related]
45. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Sawai S; Hattori T; Nishimura M; Nakaseko C
J Neurol Neurosurg Psychiatry; 2008 Nov; 79(11):1255-7. PubMed ID: 18469028
[TBL] [Abstract][Full Text] [Related]
46. Papillomacular bundle and inner retinal thicknesses correlate with visual acuity in nonarteritic anterior ischemic optic neuropathy.
Rebolleda G; Sánchez-Sánchez C; González-López JJ; Contreras I; Muñoz-Negrete FJ
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):682-92. PubMed ID: 25587057
[TBL] [Abstract][Full Text] [Related]
47. Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis.
Zaveri MS; Conger A; Salter A; Frohman TC; Galetta SL; Markowitz CE; Jacobs DA; Cutter GR; Ying GS; Maguire MG; Calabresi PA; Balcer LJ; Frohman EM
Arch Neurol; 2008 Jul; 65(7):924-8. PubMed ID: 18625859
[TBL] [Abstract][Full Text] [Related]
48. POEMS syndrome in a 20-year-old patient diagnosed following a complaint of reduced visual acuity.
Doi S; Kimura S; Morizane Y; Hosogi M; Hosokawa M; Shiode Y; Kawata T; Kondo E; Shiraga F
Acta Med Okayama; 2014 Dec; 68(6):379-83. PubMed ID: 25519033
[TBL] [Abstract][Full Text] [Related]
49. Failure of treatment with anti-VEGF monoclonal antibody for long-standing POEMS syndrome.
Kanai K; Kuwabara S; Misawa S; Hattori T
Intern Med; 2007; 46(6):311-3. PubMed ID: 17380000
[TBL] [Abstract][Full Text] [Related]
50. The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome.
D'Souza A; Hayman SR; Buadi F; Mauermann M; Lacy MQ; Gertz MA; Kyle RA; Kumar S; Greipp PR; Lust JA; Russell SJ; Zeldenrust S; Dingli D; Witzig TE; Rajkumar SV; Dispenzieri A
Blood; 2011 Oct; 118(17):4663-5. PubMed ID: 21881050
[TBL] [Abstract][Full Text] [Related]
51. Optical coherence tomography in papilledema and pseudopapilledema with and without optic nerve head drusen.
Bassi ST; Mohana KP
Indian J Ophthalmol; 2014 Dec; 62(12):1146-51. PubMed ID: 25579359
[TBL] [Abstract][Full Text] [Related]
52. Sensitivity and specificity of time-domain and spectral-domain optical coherence tomography in differentiating optic nerve head drusen and optic disc oedema.
Flores-Rodríguez P; Gili P; Martín-Ríos MD
Ophthalmic Physiol Opt; 2012 May; 32(3):213-21. PubMed ID: 22428958
[TBL] [Abstract][Full Text] [Related]
53. Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs.
Marsh ES; Keddie S; Terris-Prestholt F; D'Sa S; Lunn MP
J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):172-176. PubMed ID: 33106368
[TBL] [Abstract][Full Text] [Related]
54. Detection of mild papilloedema using spectral domain optical coherence tomography.
Vartin C V; Nguyen AM; Balmitgere T; Bernard M; Tilikete C; Vighetto A
Br J Ophthalmol; 2012 Mar; 96(3):375-9. PubMed ID: 21653211
[TBL] [Abstract][Full Text] [Related]
55. Multiple angiogenetic factors are upregulated in POEMS syndrome.
Yamada Y; Sawai S; Misawa S; Kanai K; Shibuya K; Mori M; Moriya J; Sogawa K; Yamamoto H; Beppu M; Taniguchi J; Nakaseko C; Nomura F; Kuwabara S
Ann Hematol; 2013 Jan; 92(2):245-8. PubMed ID: 23053181
[TBL] [Abstract][Full Text] [Related]
56. POEMS syndrome and calciphylaxis: an unrecognized cause of abnormal small vessel calcification.
Araki N; Misawa S; Shibuya K; Ota S; Oide T; Kawano A; Beppu M; Nakatani Y; Kuwabara S
Orphanet J Rare Dis; 2016 Apr; 11():35. PubMed ID: 27068711
[TBL] [Abstract][Full Text] [Related]
57. Autologous cytokine-induced killer (CIK) cell immunotherapy combined with cyclophosphamide in five patients with POEMS syndrome.
Ma L; Wang Y; Bo J; Han W; Wang Y; Zhang L; Wu X; Yu S; Liu R
Clin Exp Immunol; 2016 Apr; 184(1):83-9. PubMed ID: 26660736
[TBL] [Abstract][Full Text] [Related]
58. Serum vascular endothelial growth factor (VEGF) in the differential diagnosis of amyloid neuropathy and POEMS syndrome.
Econimo L; Jeannin G; Biasi L; Mazzola G; Mendeni M; Presteni K; Gregorini G
Amyloid; 2011 Jun; 18 Suppl 1():106-8. PubMed ID: 21838451
[No Abstract] [Full Text] [Related]
59. Growth factors and proinflammatory cytokines in the renal involvement of POEMS syndrome.
Soubrier M; Sauron C; Souweine B; Larroche C; Wechsler B; Guillevin L; Piette JC; Rousset H; Deteix P
Am J Kidney Dis; 1999 Oct; 34(4):633-8. PubMed ID: 10516342
[TBL] [Abstract][Full Text] [Related]
60. Intravitreal Bevacizumab for the Treatment of Optic Disc Edema in a Patient with POEMS Syndrome.
Kim DW; Kang SY; Bae HW; Hong S; Seong GJ; Kim CY
Korean J Ophthalmol; 2015 Oct; 29(5):354-6. PubMed ID: 26457044
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
